Garhyan, Parag

Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching

Detke, H. C., Zhao, F., Garhyan, P., Carlson, J., & McDonnell, D. (2011) · International Clinical Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 185

Treatment with LY 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

Guzman, C. B., Zhang, X. M., Liu, R., Regev, A., Shankar, S., Garhyan, P., Pillai, S. G., Kazda, C., Chalasani, N., & Hardy, T. A. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 172

Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist

Benichou, O., Coskun, T., Gonciarz, M. D., Garhyan, P., Adams, A. C., Du, Y., Dunbar, J. D., Martin, J. A., Mather, K. J., Pickard, R. T., et al. (2023) · Cell Metabolism

Regulation of Appetite and ObesityGDF15 and Related Biomarkers

Cited by 115

Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes

Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 110